International Journal of Innovation and Applied Studies
ISSN: 2028-9324     CODEN: IJIABO     OCLC Number: 828807274     ZDB-ID: 2703985-7
Tuesday 06 June 2023






Custom Search


  • Contact us
  • Newsletter:

Connect with IJIAS

  Now IJIAS is indexed in EBSCO, ResearchGate, ProQuest, Chemical Abstracts Service, Index Copernicus, IET Inspec Direct, Ulrichs Web, Google Scholar, CAS Abstracts, J-Gate, UDL Library, CiteSeerX, WorldCat, Scirus, Research Bible and getCited, etc.  

Magnitude of Persistent of Tuberculosis Clinical Signs after Completing Anti-TB Treatments in Ethiopia

Volume 7, Issue 4, August 2014, Pages 1306–1309

 Magnitude of Persistent of Tuberculosis Clinical Signs after Completing  Anti-TB Treatments in Ethiopia

Araya Mengistu1

1 Faculty of Veterinary Medicine, University of Gondar, Ethiopia

Original language: English

Copyright © 2014 ISSR Journals. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Tuberculosis is a worldwide problem with a considerable morbidity and mortality per annum. The disease is curable and early diagnosis and chemotherapy is very essential. Despite completing the recommended course of therapy and clearance from the disease causing agent the clinical signs persist in TB patients. The current study aimed to assess the possible claims of persistent signs which are either resulted from the drug side effects or the disease itself by the TB patients. A cross-sectional study design conducted on volunteer pulmonary tuberculosis patients. The variables included were those signs which are used to diagnose tuberculosis. Closed questionnaire with YES or NO answer was used. The current study revealed that three fourth of the treated TB patients claimed the presence of either one or more signs, while one fourth reported free from any signs which they knew before anti-TB treatment. Extra pulmonary tuberculosis (in fact it cloud be new infection) was observed on 7.1% (2/28) of the participants.
It is concluded that persistent of clinical signs after completing TB treatment courses is noteworthy. Prolonging recovery time would affect productivity. Despite the limitations the information generated suggested further study to clear out the mere cause/s of the clinical signs.

Author Keywords: patient, signs/syndromes, treatment, tuberculosis.

How to Cite this Article

Araya Mengistu, “Magnitude of Persistent of Tuberculosis Clinical Signs after Completing Anti-TB Treatments in Ethiopia,” International Journal of Innovation and Applied Studies, vol. 7, no. 4, pp. 1306–1309, August 2014.